Can Faster Aspart Be Used to Optimize Glycemic Control With Insulin Pump Therapy? From Expectations to Lessons Learned After a Year of Use in the United States

Fast-acting insulin aspart (faster aspart) is an ultra-rapid-acting formulation of insulin aspart developed to more closely match the prandial endogenous insulin profile, and its accelerated absorption kinetics are expected to provide clinical benefits for patients using insulin pump therapy. A head...

Descripción completa

Detalles Bibliográficos
Autores principales: Aleppo, Grazia, Bode, Bruce, Carlson, Anders L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2022
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606564/
https://www.ncbi.nlm.nih.gov/pubmed/36381308
http://dx.doi.org/10.2337/cd21-0056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606564/
https://www.ncbi.nlm.nih.gov/pubmed/36381308
http://dx.doi.org/10.2337/cd21-0056

Ejemplares similares